Can a PMCF Plan be e-signed?

Yes. Electronic signatures can be legally binding under the ESIGN Act (15 U.S.C. ch. 96) and UETA where adopted, provided signatory intent, consent, attribution, and secure record retention are met; healthcare data must also comply with HIPAA and any applicable state privacy laws.

Is HIPAA a concern for PMCF data?

Yes. Patient health information collected during PMCF activities is subject to HIPAA protections when transmitted or stored by covered entities or business associates. Execute a BAA with your eSignature vendor and ensure encryption, access controls, and six-year retention per 45 CFR §164.530(j).

When is notarization required?

Most PMCF Plans do not require notarization. Notarization is generally unnecessary unless specific state law or contractual terms demand it. For documents requiring notarization, consider Remote Online Notarization where permitted and follow state requirements for identity proofing and audio‑video retention.

How do I prove signature authenticity?

Collect audit trails with timestamps, IP addresses, signer email, and authentication method (SMS, KBA, SSO). Retain signed records in tamper‑evident format and preserve metadata to meet ESIGN/UETA legal tests and FDA or audit expectations where applicable.

How long should PMCF records be retained?

Retain PMCF records per applicable regulators: at least three years for tax/financial items (IRC §6501(a)), six years for HIPAA (45 CFR §164.530(j)), and longer where SEC or state law requires. Document retention policies and legal basis.

Can signNow be used for PMCF Plans?

signNow supports HIPAA (BAA available), 21 CFR Part 11 controls, SOC 2 Type II, AES‑256 at rest, and TLS 1.2/1.3 in transit; plans start at $8/user/month (site license option $1.50/signature invite). Verify BAA and feature set meet institutional requirements before use.

Electronic Signature
Templates
Healthcare
Healthcare PMCF Plan

Healthcare PMCF Plan

This template is fully customizable. Edit the text, fill out the fields, and send it for signature. Give it a try!

HEALTHCARE PMCF PLAN

1. Patient Information

Patient Full Legal Name

Date of Birth:

Gender:

Phone:

Address Emergency Contact (Name, Relationship, Phone)

2. Insurance Information

Primary Insurer

Policy Number:

Group Number:

Subscriber Name (if different)

3. Device and Implant Information

Device Trade Name / Model

Catalog / Model No.:

Serial / UDI:

Date of Implant/Procedure:

Implanting Facility / Physician

4. PMCF Plan Overview

Plan Objective: This Post-Market Clinical Follow-up (PMCF) Plan documents the follow-up activities intended to collect clinical data related to safety and performance of the device after placement in a patient. The objective is to detect previously unrecognized hazards, verify established safety and performance, and confirm long-term outcomes in routine clinical use.

PMCF Plan Identifier

5. Methods, Data Collection and Endpoints

Data Sources and Methods: Data will be collected through scheduled clinical assessments, patient-reported outcome instruments, device interrogation (if applicable), medical record review, and active solicitation of adverse event reports. Data collection will be performed in accordance with protocol-defined procedures.

Primary Clinical Endpoints Secondary Endpoints / Safety Outcomes

Anticipated Sample Size:

Follow-up Duration per Patient:

Scheduled Follow-Up Visits and Assessments

6. Risks, Benefits and Alternatives

Risks and Adverse Events: The known and foreseeable risks associated with the device and follow-up procedures are disclosed below. Participation in PMCF includes active monitoring for adverse events and reporting obligations. Clinical staff will provide appropriate care for any device-related adverse event.

Known Risks and Potential Complications

Benefits: Participation may provide additional clinical monitoring and contribute to the understanding of device safety and performance. There is no guarantee of direct clinical benefit beyond standard care.

7. Withdrawal and Study Termination

Voluntary Participation and Right to Withdraw: Participation in the PMCF plan is voluntary. The patient may withdraw consent at any time without penalty or loss of medical benefits. Withdrawal will not affect the patient’s standard clinical care. Withdrawn participants' data will be handled according to the consent terms below.

8. Data Use, Confidentiality and HIPAA Acknowledgment

Confidentiality and Data Handling: Data collected pursuant to this PMCF plan will be maintained confidentially by the sponsor and clinical sites. Identifiable information will be used only as necessary for follow-up and regulatory reporting. Reasonable safeguards will be implemented to protect data integrity and privacy.

Patient Authorization for Use of Protected Health Information

By initialing and signing below the patient authorizes release and use of relevant medical records, diagnostic images, and device data for the purposes set forth in this PMCF plan, including regulatory reporting and post-market surveillance. The patient acknowledges receipt of the privacy notice and understands the scope of data use.

I acknowledge and authorize:

Authorization Expiration Date

9. Adverse Event Reporting and Sponsor Responsibilities

Adverse Event Reporting: The clinical site will report device-related adverse events to the sponsor and appropriate regulatory bodies in accordance with applicable reporting timelines. The patient agrees to notify the clinical contact for any unexpected symptoms, device malfunctions, or hospitalizations potentially related to the device.

Clinical Contact for PMCF Questions or Adverse Events

10. Medical History Relevant to PMCF

Current Medications Allergies Relevant Medical / Surgical History

11. Protocol Deviations and Data Retention

Protocol Deviations: Any deviation from the PMCF plan required for patient safety or emergent medical care will be documented in the patient record and reported according to sponsor procedures. Data Retention: Study data will be retained in accordance with applicable regulatory requirements and sponsor policy.

12. Certification and Consent

By signing below I certify that I have read and understand the information contained in this PMCF Plan, that my questions have been answered, and that I voluntarily agree to participate in the described follow-up activities. I understand that I may withdraw at any time and that participation does not alter my standard of care.

Patient Name:

Signature:

Relationship to Patient (if signer is guardian):

Date:

What a Healthcare PMCF Plan Is and Why It Matters

The Healthcare PMCF Plan (post‑market clinical follow‑up plan) documents a device sponsor's structured approach to gathering clinical data after market placement to confirm long‑term safety and performance. It defines objectives, study design, data sources, sampling, endpoints, and reporting timelines used to detect emerging risks, validate risk‑control measures, and support labeling or regulatory submissions. While PMCF is a term used in international regulatory frameworks, similar activities in the United States align with FDA postmarket surveillance and post‑approval study practices; plans should reference applicable regulatory obligations and privacy requirements such as HIPAA when patient data are involved.

Why a Clear PMCF Plan Reduces Risk

A Healthcare PMCF Plan provides systematic evidence collection to monitor device performance, identify trends, and support regulatory compliance. It reduces regulatory risk, documents corrective actions, and provides data for labeling updates or safety communications while helping satisfy postmarket obligations under FDA and international requirements.

Who Typically Prepares and Uses a PMCF Plan

Primary users include device manufacturers, clinical teams, regulatory affairs professionals, and contracted clinical research organizations responsible for postmarket monitoring.

Regulatory affairs: prepares and maintains PMCF documentation for submissions and audits.
Clinical operations: designs studies, manages data collection, and oversees patient follow‑up.
Quality and vigilance teams: analyze trends, initiate corrective actions, and report adverse events.

External stakeholders may include notified bodies, sponsors' clinical partners, and health authorities reviewing postmarket evidence.

Core Elements Every Healthcare PMCF Plan Should Include

A professional Healthcare PMCF Plan includes clear objectives, robust methods, defined data sources, analysis plans, reporting triggers, and governance for decision making and follow-up actions.

Objectives

Define specific clinical questions, primary and secondary endpoints, measurable performance targets, and thresholds for safety signals that will prompt further investigation or corrective actions, including timelines.

Study Design

Specify observational cohort, registry linkage, prospective study, or targeted follow‑up; outline inclusion criteria, sampling methods, comparison groups, and data handling procedures.

Data Sources

List clinical registries, electronic health records, claims datasets, patient surveys, and manufacturer device registries; document data quality checks and data provenance procedures for longitudinal tracking.

Analysis Plan

Describe statistical methods, interim analysis schedules, subgroup analyses, handling of missing data, and criteria for signal detection, including multiplicity adjustments and sensitivity analyses.

Reporting

Set timelines for periodic safety reviews, expedited reporting of serious events, submission to regulators or notified bodies, and public communications when necessary, with version control and distribution lists.

Governance

Identify responsible parties, roles for data review and decision making, change control processes, escalation pathways, and documentation of corrective actions with committee charters and meeting schedules.

Sequential Checklist to Draft and Implement a PMCF Plan

Follow this sequential checklist to draft, review, and implement a Healthcare PMCF Plan aligned with clinical and regulatory expectations.

01

Define Objectives: Specify safety and performance questions the PMCF will address.
02

Design Methods: Choose study type, sample size, and data sources.
03

Data Collection: Establish case report forms, EHR extracts, and device registries.
04

Reporting: Set timelines for analysis, safety reports, and regulatory submissions.

Field	Configuration
Authentication	Email plus SMS code verification
Consent	ESIGN consumer disclosure required prior to signing
Audit Trail	Enable timestamps, IP, and action log
Document Format	Use PDF/A or certified PDF

Technical and Integration Requirements for Secure PMCF Workflows

Choose a platform that supports HIPAA BAA, audit trails, RON support, integrations, and common file formats used in clinical documentation.

Integrations: Salesforce, Microsoft 365, NetSuite
Formats: PDF, DOCX, HTML, Excel
Security: AES-256 at rest, TLS 1.2/1.3

Security and Compliance Controls to Verify

Encryption: TLS 1.2/1.3 in transit; AES-256 at rest

Certifications: SOC 2 Type II; ISO 27001; PCI DSS

HIPAA: Supported with BAA option

Audit Trail: Documented timestamps, IP, action logs

21 CFR Part 11: Supports electronic records and signatures

Access Controls: Role-based permissions and SSO

Common Mistakes to Avoid When Preparing a PMCF Plan

Undefined objectives lead to unfocused data collection and inconclusive analyses that fail to address safety or performance hypotheses.
Inadequate sample sizes and unclear inclusion criteria produce underpowered studies that cannot detect clinically meaningful trends or rare adverse events.
Poor data provenance, inconsistent identifiers, and missing informed consent documentation create compliance and traceability issues under HIPAA and regulatory review.
Delays in reporting or failing to update the PMCF Plan after new findings may trigger regulatory inquiries or corrective actions.

Key Risks and Potential Consequences

Regulatory Action: FDA enforcement for inadequate postmarket studies

HIPAA Violation: Civil penalties and corrective plans

Invalid Evidence: Poor data quality undermines conclusions

Delayed Response: Missed safety signals escalate risk

Financial Penalties: Fines, litigation, and product holds

Reputation: Loss of clinician and patient trust

Typical Vendor Pricing and Feature Comparison for eSignature Solutions

Compare typical starting prices and key feature distinctions among common eSignature vendors used for clinical and regulatory workflows.

	signNow	DocuSign	Adobe Sign	PandaDoc	HelloSign
Starting Price	$8/user/mo	$15/user/mo	$14/user/mo	$19/user/mo	$15/user/mo
Free Trial	7-day trial	No	No	Yes, limited	Yes, limited
Bulk Send	Yes	Yes	Yes	Yes	No
Audit Trail	Yes	Yes	Yes	Yes	Yes
HIPAA Compliant	Yes	Yes	Yes	No	No
Envelope Cap	No cap	100 envelopes/user/year	No cap	No cap	No cap

Short Real-World PMCF Examples

Two concise examples show how sponsors implement PMCF Plans across devices and study designs efficiently.

Hospital Device Registry

A mid-size manufacturer established a hospital-based registry to track long‑term outcomes for an implanted monitoring device over three years.

Registry linked to EHRs and device logs.
Results identified a rare device‑related complication prompting label updates and a targeted training program; the registry's quality controls and audit trail supported regulatory reporting and reduced uncertainty about device performance across diverse clinical settings.

Post-Approval Study

A sponsor conducted a multicenter post‑approval prospective study to evaluate device effectiveness in a broader patient population.

Interim analyses triggered additional subgroup analyses.
Interim safety reviews led to a protocol amendment improving follow‑up schedules; transparent documentation and timely e‑submissions supported communications with health authorities and maintained market access while preserving patient safety oversight.

FAQs and Troubleshooting for Completing a PMCF Plan

Frequently asked questions and troubleshooting for completing, executing, and storing a Healthcare PMCF Plan, including electronic signatures and compliance considerations.

Need help? Contact support

Can a PMCF Plan be e-signed?
Yes. Electronic signatures can be legally binding under the ESIGN Act (15 U.S.C. ch. 96) and UETA where adopted, provided signatory intent, consent, attribution, and secure record retention are met; healthcare data must also comply with HIPAA and any applicable state privacy laws.
Is HIPAA a concern for PMCF data?
Yes. Patient health information collected during PMCF activities is subject to HIPAA protections when transmitted or stored by covered entities or business associates. Execute a BAA with your eSignature vendor and ensure encryption, access controls, and six-year retention per 45 CFR §164.530(j).
When is notarization required?
Most PMCF Plans do not require notarization. Notarization is generally unnecessary unless specific state law or contractual terms demand it. For documents requiring notarization, consider Remote Online Notarization where permitted and follow state requirements for identity proofing and audio‑video retention.
How do I prove signature authenticity?
Collect audit trails with timestamps, IP addresses, signer email, and authentication method (SMS, KBA, SSO). Retain signed records in tamper‑evident format and preserve metadata to meet ESIGN/UETA legal tests and FDA or audit expectations where applicable.
How long should PMCF records be retained?
Retain PMCF records per applicable regulators: at least three years for tax/financial items (IRC §6501(a)), six years for HIPAA (45 CFR §164.530(j)), and longer where SEC or state law requires. Document retention policies and legal basis.
Can signNow be used for PMCF Plans?
signNow supports HIPAA (BAA available), 21 CFR Part 11 controls, SOC 2 Type II, AES‑256 at rest, and TLS 1.2/1.3 in transit; plans start at $8/user/month (site license option $1.50/signature invite). Verify BAA and feature set meet institutional requirements before use.

be ready to get more

Join over 28 million airSlate SignNow users

Sign Now